Jean-Louis Constanza is one of the founders, and Chief Clinical and Development Officer, of Wandercraft. In the last 5 years he worked with many medical teams to adapt Wandercraft’s exo, the first autonomous walk robotic exoskeleton, to the needs of Neuro and PMR institutions and their patients. He has a 30 years experience in digital and robotics industries and start-ups.
Autonomous Walk Exoskeleton: first learnings from clinical trials and expectations
The first autonomous walk exoskeleton has been tested since 2017 and is now being used for patient treatment in Europe. The seminar aim is to present and discuss preliminary learnings, on-going clinical studies and expected impact on treatment for stroke patients and patients with severe gait disorder.
EVEN MORE SEMINARS
Andrew Bateman PhD MCSP University of Essex, School of Health and Social Care
Neuropsychological Rehabilitation Research: how to win funds and change services
Dr Elizabeth Iveson Lives On Medical
From Secondary to Primary care and beyond.. Challenges in the longer term management and rehabilitation following Stroke and Acquired Brain Injury. Wh
Dr Najma Khan-Bourne King’s College Hospital NHS Foundation Trust
Neuropsychological evaluation and formulation in acute stroke rehabilitation
Dr. Stephen Barabas K-Laser UK Ltd
Class IV Therapy Laser for Neurorehabilitation and Pain Management
Dr Anita Rose The Raphael Hospital
Mental Health and Brain Injury: Promoting mental wellbeing